|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/15/23 Neogen Corp. 10-K 5/31/23 92:19M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 4.71M
2: EX-21 Subsidiaries List HTML 59K
3: EX-23 Consent of Expert or Counsel HTML 26K
4: EX-24 Power of Attorney HTML 58K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 32K
7: EX-32 Certification -- §906 - SOA'02 HTML 29K
13: R1 Cover Page HTML 93K
14: R2 Consolidated Balance Sheets HTML 157K
15: R3 Consolidated Balance Sheets (Parenthetical) HTML 42K
16: R4 Consolidated Statements of Income (Loss) HTML 113K
17: R5 Consolidated Statements of Comprehensive Income HTML 55K
(Loss)
18: R6 Consolidated Statements of Comprehensive Income HTML 30K
(Loss)(Parenthetical)
19: R7 Consolidated Statements of Stockholders' Equity HTML 79K
20: R8 Consolidated Statements of Cash Flows HTML 119K
21: R9 Summary of Significant Accounting Policies HTML 431K
22: R10 Goodwill and Other Intangible Assets HTML 195K
23: R11 Business Combinations HTML 181K
24: R12 Long Term Debt HTML 95K
25: R13 Equity Compensation Plans HTML 300K
26: R14 Income Taxes HTML 380K
27: R15 Commitments and Contingencies HTML 46K
28: R16 Defined Contribution Benefit Plan HTML 33K
29: R17 Fair Value and Derivatives HTML 130K
30: R18 Segment Information HTML 283K
31: R19 Summary of Significant Accounting Policies HTML 474K
(Policies)
32: R20 Summary of Significant Accounting Policies HTML 382K
(Tables)
33: R21 Goodwill and Other Intangible Assets (Tables) HTML 175K
34: R22 Business Combinations (Tables) HTML 118K
35: R23 Long Term Debt (Tables) HTML 68K
36: R24 Equity Compensation Plans (Tables) HTML 280K
37: R25 Income Taxes (Tables) HTML 375K
38: R26 Fair Value and Derivatives (Tables) HTML 121K
39: R27 Segment Information (Tables) HTML 278K
40: R28 Summary of Significant Accounting Policies - HTML 101K
Additional Information (Detail)
41: R29 Marketable Securities (Detail) HTML 35K
42: R30 Components of marketable securities (Details) HTML 36K
43: R31 Activity in Allowance for Doubtful Accounts HTML 36K
(Detail)
44: R32 Inventories (Detail) HTML 36K
45: R33 Calculation of Net (Loss) Income per Share HTML 61K
(Detail)
46: R34 Supplemental Balance Sheet Information Related to HTML 35K
Operating Leases (Detail)
47: R35 Weighted Average Remaining Lease Term and Weighted HTML 29K
Average Discount Rate (Detail)
48: R36 Components of Lease Expense (Detail) HTML 31K
49: R37 Undiscounted Minimum Lease Payments (Detail) HTML 45K
50: R38 Disaggregated Revenue (Detail) HTML 56K
51: R39 Goodwill and Other Intangible Assets - Additional HTML 78K
Information (Detail)
52: R40 Goodwill by Business Segment (Detail) HTML 42K
53: R41 Amortizable of Intangible Assets (Detail) HTML 53K
54: R42 Business Combinations - Additional Information HTML 229K
(Detail)
55: R43 Business Combinations - Summary of Preliminary HTML 75K
Fair Values of Assets Acquired And Liabilities
Assumed As of The Date of Acquisition (Detail)
56: R44 Business Combinations - Summary of Finite-Lived HTML 38K
Intangible Assets Acquired as Part of Business
Combination (Details)
57: R45 Business Combinations - Summary of Business HTML 40K
Acquisition, Unaudited Pro Forma Information
(Details)
58: R46 Long Term Debt - Summary of Long Term Debt HTML 38K
(Detail)
59: R47 Long Term Debt - Additional Information (Detail) HTML 143K
60: R48 Long Term Debt - Summary of Expected Maturities HTML 47K
Associated With Outstanding Debt (Detail)
61: R49 Equity Compensation Plans - Additional Information HTML 76K
(Detail)
62: R50 Stock Option Activity (Detail) HTML 57K
63: R51 Stock Option Activity (Parenthetical) (Detail) HTML 29K
64: R52 Summary of Stock Options Outstanding (Detail) HTML 66K
65: R53 Schedule of Share-based Compensation Arrangement HTML 31K
by Share-based Payment Award, Options Intrinsic
Value (Detail)
66: R54 Equity Compensation Plans - Summary of Fair Value HTML 36K
of Stock Options Granted Estimated
Weighted-Average Assumptions (Details)
67: R55 Equity Compensation Plans - Schedule Of Nonvested HTML 48K
Restricted Stock Units Activity (Detail)
68: R56 Income Before Income Taxes (Detail) HTML 35K
69: R57 Provision for Income Taxes (Detail) HTML 55K
70: R58 Reconciliation of Income Taxes Computed at the HTML 62K
U.S. Federal Statutory Tax Rate to Income Tax
Expense (Detail)
71: R59 Income Taxes - Additional Information (Detail) HTML 42K
72: R60 Significant Components of Deferred Income Tax HTML 61K
Liabilities and Assets (Detail)
73: R61 Operating Loss Carry forwards (Detail) HTML 34K
74: R62 Reconciliation of Our Tax Contingencies (Detail) HTML 35K
75: R63 Commitments and Contingencies - Additional HTML 76K
Information (Detail)
76: R64 Defined Contribution Benefit Plan - Additional HTML 35K
Information (Detail)
77: R65 Fair Value and Derivatives - Additional HTML 54K
Information (Detail)
78: R66 Fair Value and Derivatives - Schedule of Other HTML 32K
Derivatives Not Designated As Hedging Instruments
Statements of Financial Performance And Financial
Position Location (Detail)
79: R67 Fair Value and Derivatives - Schedule of Gain Loss HTML 33K
From Derivatives Not Designated As Hedging
Instruments Statements of Financial Performance
And Location (Detail)
80: R68 Fair Value and Derivatives - Summary of Interest HTML 34K
Rate Swaps on Recurring Basis Using Observable
Market Inputs for Similar Assets or Liabilities
(Details)
81: R69 Fair Value and Derivatives - Summary of Fair Value HTML 32K
of Term Loan and Senior Notes (Detail)
82: R70 Fair Value and Derivatives - Summary of Other HTML 32K
Comprehensive Income (Loss) Before
Reclassifications of Derivative Gains and Losses
(Details)
83: R71 Fair Value and Derivatives - Summary of HTML 33K
Reclassification of Derivative Gains and Losses
into Net Income from Accumulated Other
Comprehensive Income (Loss) (Details)
84: R72 Segment Information - Additional Information HTML 28K
(Detail)
85: R73 Segment Information (Detail) HTML 73K
86: R74 Disaggregated Revenue by Geographic Location HTML 36K
(Detail)
87: R75 Segment Information - Summary of Net Property and HTML 35K
Equipment Disaggregated by Country (Detail)
90: XML IDEA XML File -- Filing Summary XML 167K
88: XML XBRL Instance -- neog-20230531_htm XML 5.04M
89: EXCEL IDEA Workbook of Financial Report Info XLSX 192K
11: EX-101.CAL XBRL Calculations -- neog-20230531_cal XML 195K
10: EX-101.DEF XBRL Definitions -- neog-20230531_def XML 1.46M
9: EX-101.LAB XBRL Labels -- neog-20230531_lab XML 1.89M
8: EX-101.PRE XBRL Presentations -- neog-20230531_pre XML 1.61M
12: EX-101.SCH XBRL Schema -- neog-20230531 XSD 228K
91: JSON XBRL Instance as JSON Data -- MetaLinks 603± 980K
92: ZIP XBRL Zipped Folder -- 0000950170-23-042861-xbrl Zip 564K
| EX-32 |
EXHIBIT 32
NEOGEN CORPORATION
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Annual Report on Form 10-K of Neogen Corporation (the “Company”) for the period ended May 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John E. Adent, as Chief Executive Officer and I, David H. Naemura, as Chief Financial Officer, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
Date: August 15, 2023
/s/ John E. Adent
|
President & Chief Executive Officer |
(Principal Executive Officer) |
|
/s/ David H. Naemura
|
Chief Financial Officer |
(Principal Financial and Accounting Officer) |
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/15/23 | |||
| For Period end: | 5/31/23 | NT 10-K | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/01/22 Neogen Corp. 8-K:1,2,5,8 9/01/22 23:5.6M Broadridge Fin’l So… Inc 7/27/22 Neogen Corp. 10-K 5/31/22 85:10M Donnelley … Solutions/FA 7/27/22 Neogen Corp. S-4/A 7:10M Broadridge Fin’l So… Inc 3/17/22 Neogen Corp. 8-K:5,9 3/14/22 11:1.3M Broadridge Fin’l So… Inc 12/15/21 Neogen Corp. 8-K:1,9 12/13/21 14:1.6M Donnelley … Solutions/FA 7/30/20 Neogen Corp. 10-K 5/31/20 80:13M Donnelley … Solutions/FA 12/28/18 Neogen Corp. 10-Q 11/30/18 52:4.6M Donnelley … Solutions/FA 12/30/11 Neogen Corp. 10-Q 11/30/11 47:2.9M Donnelley … Solutions/FA 4/14/00 Neogen Corp. 10-Q 2/29/00 5:172K Reardon Parshall Co./FA |